A Prospective Surveillance Trial to Evaluate the Safety of Optison in Clinical Practice.

Completed · Phase 4

Conditions studied: Echocardiography

In brief

This prospective surveillance trial will gather safety information for Optison when it is used in routine practice.

Key facts

Study ID

NCT00730964

Run by

GE Healthcare

People needed

1039

Starts

2008-05-01

Expected to finish

2009-10-01

Last updated by the study team

2012-06-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• The subject is over 18 years old.
• The subject has been scheduled for an Optison-enhanced echocardiography exam.
• The subject has provided signed and dated informed consent.

You may not qualify if…

• Known hypersensitivity to perflutren, blood, blood products or albumin.

Where it is running

• GE Healthcare — Princeton, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.